JP2015535209A - 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用 - Google Patents

慢性腎臓病患者の治療におけるクエン酸第二鉄の使用 Download PDF

Info

Publication number
JP2015535209A
JP2015535209A JP2015518623A JP2015518623A JP2015535209A JP 2015535209 A JP2015535209 A JP 2015535209A JP 2015518623 A JP2015518623 A JP 2015518623A JP 2015518623 A JP2015518623 A JP 2015518623A JP 2015535209 A JP2015535209 A JP 2015535209A
Authority
JP
Japan
Prior art keywords
ferric citrate
iron
ckd
patient
ferric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015518623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015535209A5 (https=
Inventor
ポラドス エンリクエ
ポラドス エンリクエ
ベントスル ロン
ベントスル ロン
エフ．オリビエロ サード ジェームス
エフ．オリビエロ サード ジェームス
Original Assignee
ケリク バイオファーマシューティカルス， インコーポレーテッド
ケリク バイオファーマシューティカルス， インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ケリク バイオファーマシューティカルス， インコーポレーテッド, ケリク バイオファーマシューティカルス， インコーポレーテッド filed Critical ケリク バイオファーマシューティカルス， インコーポレーテッド
Publication of JP2015535209A publication Critical patent/JP2015535209A/ja
Publication of JP2015535209A5 publication Critical patent/JP2015535209A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015518623A 2012-06-21 2013-06-21 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用 Pending JP2015535209A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261662565P 2012-06-21 2012-06-21
US61/662,565 2012-06-21
US201361757229P 2013-01-28 2013-01-28
US61/757,229 2013-01-28
US201361800618P 2013-03-15 2013-03-15
US201361801050P 2013-03-15 2013-03-15
US61/801,050 2013-03-15
US61/800,618 2013-03-15
PCT/US2013/047134 WO2013192565A2 (en) 2012-06-21 2013-06-21 Use of ferric citrate in the treatment of chronic kidney disease patients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018075243A Division JP2018138562A (ja) 2012-06-21 2018-04-10 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用

Publications (2)

Publication Number Publication Date
JP2015535209A true JP2015535209A (ja) 2015-12-10
JP2015535209A5 JP2015535209A5 (https=) 2016-08-12

Family

ID=49769729

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015518623A Pending JP2015535209A (ja) 2012-06-21 2013-06-21 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP2018075243A Pending JP2018138562A (ja) 2012-06-21 2018-04-10 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP2020029756A Pending JP2020100638A (ja) 2012-06-21 2020-02-25 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP2022019167A Pending JP2022070945A (ja) 2012-06-21 2022-02-10 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018075243A Pending JP2018138562A (ja) 2012-06-21 2018-04-10 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP2020029756A Pending JP2020100638A (ja) 2012-06-21 2020-02-25 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP2022019167A Pending JP2022070945A (ja) 2012-06-21 2022-02-10 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用

Country Status (19)

Country Link
US (3) US20130345303A1 (https=)
EP (3) EP3730136B1 (https=)
JP (4) JP2015535209A (https=)
KR (2) KR20200103855A (https=)
CN (2) CN113244209A (https=)
AU (2) AU2013278000A1 (https=)
BR (1) BR112014032049A2 (https=)
CA (1) CA2876982A1 (https=)
DK (1) DK3730136T3 (https=)
EA (1) EA201590062A1 (https=)
ES (2) ES2796254T3 (https=)
FR (1) FR25C1043I1 (https=)
HK (1) HK1214503A1 (https=)
IL (1) IL236356A0 (https=)
MX (1) MX2014015615A (https=)
NO (1) NO2025048I1 (https=)
PL (1) PL3730136T3 (https=)
SG (2) SG11201408521WA (https=)
WO (1) WO2013192565A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019059172A1 (ja) 2017-09-19 2019-03-28 日本たばこ産業株式会社 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108938585A (zh) 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型
TWI653043B (zh) * 2012-12-20 2019-03-11 瑞士商伊蘭科動物健康公司 新用途
SI3287133T1 (sl) 2013-06-05 2019-09-30 Tricida Inc. Polimeri, ki vežejo protone,za peroralno dajanje
ES2856261T3 (es) * 2013-10-01 2021-09-27 Fresenius Medical Care Deutschland Gmbh Método y aparatos para determinar una pérdida diaria de hierro de un paciente
HK1223031A1 (zh) * 2013-11-04 2017-07-21 凯克斯生物制药公司 用於降低慢性肾病患者的心力衰竭的枸橼酸铁
WO2015110968A1 (en) * 2014-01-23 2015-07-30 Lupin Limited Pharmaceutical grade ferric citrate and method for its production
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
LT3229816T (lt) 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
US20180071243A1 (en) * 2015-03-04 2018-03-15 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of iron-deficiency anemia
CN104688706B (zh) * 2015-04-01 2017-07-14 成都欣捷高新技术开发有限公司 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法
WO2016162794A1 (en) * 2015-04-08 2016-10-13 Leiutis Pharmaceuticals Pvt Ltd Pharmaceutical compositions of ferric citrate
WO2016162888A1 (en) * 2015-04-09 2016-10-13 Actavis Group Ptc Ehf. Process for preparing pharmaceutical grade ferric citrate
WO2017193024A1 (en) 2016-05-06 2017-11-09 Tricida, Inc. Hcl-binding compositions for and method of treating acid-base disorders
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
WO2019236639A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
JP2022505697A (ja) 2018-10-29 2022-01-14 ファーマコスモス ホールディング エー／エス カルボキシマルトース第二鉄による鉄欠乏症の治療
WO2022150623A1 (en) 2021-01-08 2022-07-14 Akebia Therapeutics, Inc. Compounds and composition for the treatment of anemia
CN117999069A (zh) 2021-05-27 2024-05-07 凯克斯生物制药公司 柠檬酸铁的儿科调配物
CN115024495B (zh) * 2022-06-27 2024-03-22 北京金康普食品科技有限公司 改善肾病患者钙磷代谢的营养组合物及其应用
WO2025181559A1 (en) * 2024-02-29 2025-09-04 Sloiron, Inc. Methods for determining the amount of encapsulated and free iron in a sample

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001506262A (ja) * 1996-12-16 2001-05-15 チェン シン スー 腎不全の治療方法
JP2009525276A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 慢性腎疾患の治療法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0922461A4 (en) * 1996-07-19 2002-07-17 Nikken Chemicals Co Ltd MEDICINE AGAINST HYPERPHOSPHATANEMIA
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1600302A (zh) * 2003-09-22 2005-03-30 宝龄富锦生技股份有限公司 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
NZ566743A (en) 2005-08-18 2010-07-30 Globoasia Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
EP1973549B1 (en) * 2006-01-06 2016-07-20 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
CN108938585A (zh) * 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001506262A (ja) * 1996-12-16 2001-05-15 チェン シン スー 腎不全の治療方法
JP2009525276A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 慢性腎疾患の治療法

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
"A 4-week dose-ranging and efficacy trial of KRX-0502(Ferric Citrate) in patients with end-stage rena", CLINICALTRIALS.GOV.ARCHIVE, JPN6017008914, 4 January 2011 (2011-01-04), ISSN: 0003519711 *
"Trial of a new formulation of KRX-0502(Ferric citrate) in patients with end-stage renal disease", CLINICALTRIALS.GOV ARCHIVE, JPN6017008913, 2 June 2010 (2010-06-02), ISSN: 0003519710 *
"エビデンスに基づくＣＫＤ診療ガイドライン２００９", 日本腎臓学会誌, vol. ５１巻，８号, JPN6017047399, 2009, pages 955 - 957, ISSN: 0003699744 *
"慢性腎臓病患者における腎性貧血治療のガイドライン", 日本透析学会雑誌, vol. ４１巻、１０号, JPN6017047398, 2008, pages 662 - 716, ISSN: 0003699745 *
AM J KIDNEY DIS., vol. 57, no. 4, JPN6017008907, 2011, pages 89 - 292, ISSN: 0003699738 *
AM J NEPHROL, vol. 36, JPN6017008904, 2012, pages 478 - 487, ISSN: 0003519704 *
KIDNEY RES CLIN PRACT, vol. 31, JPN6017008909, 20 June 2012 (2012-06-20), pages 38 - 90, ISSN: 0003699740 *
NEPHROL DIAL TRANSPLANT, vol. 17, JPN6017008905, 2002, pages 265 - 270, ISSN: 0003519705 *
NEPHROLOGY DIALYSIS TRANSPLANTATION, vol. Vol.27, Suppl. 2, JPN7017000907, May 2012 (2012-05-01), pages 490 - 536, ISSN: 0003699739 *
VALUE IN HEALTH, vol. 15, no. 4, JPN6017008911, 2 June 2012 (2012-06-02), pages 155 - 16, ISSN: 0003699741 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019059172A1 (ja) 2017-09-19 2019-03-28 日本たばこ産業株式会社 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用

Also Published As

Publication number Publication date
ES2796254T3 (es) 2020-11-26
EP3730136B1 (en) 2023-12-27
EP4335436A3 (en) 2024-05-15
US20140234416A1 (en) 2014-08-21
HK1214503A1 (zh) 2016-07-29
EP2863906B1 (en) 2020-03-18
EP4335436A2 (en) 2024-03-13
IL236356A0 (en) 2015-02-26
CN113244209A (zh) 2021-08-13
WO2013192565A2 (en) 2013-12-27
AU2018203205B2 (en) 2020-03-12
KR20200103855A (ko) 2020-09-02
MX2014015615A (es) 2015-03-20
US20150079168A1 (en) 2015-03-19
JP2020100638A (ja) 2020-07-02
HK1210013A1 (en) 2016-04-15
SG10201805177PA (en) 2018-07-30
BR112014032049A2 (pt) 2017-07-25
JP2022070945A (ja) 2022-05-13
AU2013278000A1 (en) 2015-01-22
CA2876982A1 (en) 2013-12-27
US20130345303A1 (en) 2013-12-26
PL3730136T3 (pl) 2024-03-25
DK3730136T3 (da) 2024-01-22
KR102150135B1 (ko) 2020-08-31
EP2863906A2 (en) 2015-04-29
NO2025048I1 (no) 2025-11-06
ES2970050T3 (es) 2024-05-24
AU2018203205A1 (en) 2018-05-31
EA201590062A1 (ru) 2016-02-29
EP3730136A1 (en) 2020-10-28
WO2013192565A3 (en) 2015-10-15
JP2018138562A (ja) 2018-09-06
CN104884055A (zh) 2015-09-02
FR25C1043I1 (fr) 2026-01-02
KR20150036131A (ko) 2015-04-07
SG11201408521WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
JP2022070945A (ja) 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP6828100B2 (ja) 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
KR20160105499A (ko) 철 트리말톨의 복용량 양생법
CN107530310A (zh) 柠檬酸铁在治疗缺铁性贫血中的用途
US20240041816A1 (en) Use of ferric citrate in the treatment of chronic kidney disease patients
US20190269645A1 (en) Use of ferric citrate in the treatment of chronic kidney disease patients
HK1210013B (en) Use of ferric citrate in the treatment of chronic kidney disease patients
NZ742524A (en) Use of ferric citrate in the treatment of chronic kidney disease patients

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160621

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170321

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170921

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20171212